Dernières nouvelles pour RAPT Therapeutics (NASDAQ:RAPT) Stock

RAPT THERAPEUTICS INC

RAPT Therapeutics

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

RAPT Therapeutics Inc

Press Releases

RAPT Therapeutics Announces $150 Million Private Placement

News

Management

RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company's Board of Directors

RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Earnings

RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

RAPT Therapeutics to Participate in Upcoming Investor Conferences

Health Care

RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development

RAPT Therapeutics Reports First Quarter 2025 Financial Results

RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split

RAPT Therapeutics Names Two Industry Veterans to its Board of Directors

CTNM

RAPT

Agenus

Alector

Anika Therapeutics

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

Crescent Biopharma

Cellectis S.A. - American Depositary Shares

Cellectis

Cargo Therapeutics

Design Therapeutics

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Galectin Therapeutics Inc. - Common Stock

Galectin Therapeutics

Genfit

I-MAB

Immuneering Corporation - Class A Common Stock

Immuneering

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Larimar Therapeutics, Inc. - Common Stock

Larimar Therapeutics

Nuvectis Pharma

Puma Biotechnology

SELLAS Life Sciences Group, Inc. - Common Stock

SELLAS Life Sciences Gr

Instil Bio

Tiziana Life Sciences Ltd - Common Shares

Tiziana Life Sciences

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences

Voyager Therapeutics, Inc. - Common Stock

Comments

RAPT Therapeutics

Actualités

Dernières nouvelles pour RAPT Therapeutics (NASDAQ:RAPT) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL